These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19189109)

  • 1. Magnetic resonance imaging for evaluation of disease activity in Crohn's disease: a systematic review.
    Horsthuis K; Bipat S; Stokkers PC; Stoker J
    Eur Radiol; 2009 Jun; 19(6):1450-60. PubMed ID: 19189109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Grading of Crohn's disease activity using CT, MRI, US and scintigraphy: a meta-analysis.
    Puylaert CA; Tielbeek JA; Bipat S; Stoker J
    Eur Radiol; 2015 Nov; 25(11):3295-313. PubMed ID: 26080794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Magnetic resonance imaging for evaluation of bowel inflammation and disease activity in Crohn's disease: A systematic review and meta-analysis.
    Meng XF; Lin QY; Yin HL; Li ZQ
    Gastroenterol Hepatol; 2023 May; 46(5):336-349. PubMed ID: 36243254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Training readers to improve their accuracy in grading Crohn's disease activity on MRI.
    Tielbeek JA; Bipat S; Boellaard TN; Nio CY; Stoker J
    Eur Radiol; 2014 May; 24(5):1059-67. PubMed ID: 24563158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral adiposity and inflammatory bowel disease.
    Rowan CR; McManus J; Boland K; O'Toole A
    Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is magnetic resonance imaging a reliable diagnostic tool in the evaluation of active Crohn's disease in the small bowel?
    Wu LM; Xu JR; Gu HY; Hua J; Hu J
    J Clin Gastroenterol; 2013 Apr; 47(4):328-38. PubMed ID: 23340059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging compared with ileocolonoscopy in evaluating disease severity in Crohn's disease.
    Florie J; Horsthuis K; Hommes DW; Nio CY; Reitsma JB; van Deventer SJ; Stoker J
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1221-8. PubMed ID: 16361048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methotrexate for induction of remission in refractory Crohn's disease.
    McDonald JW; Tsoulis DJ; Macdonald JK; Feagan BG
    Cochrane Database Syst Rev; 2012 Dec; 12():CD003459. PubMed ID: 23235598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic review: the use of ultrasonography, computed tomography and magnetic resonance imaging for the diagnosis, assessment of activity and abdominal complications of Crohn's disease.
    Panés J; Bouzas R; Chaparro M; García-Sánchez V; Gisbert JP; Martínez de Guereñu B; Mendoza JL; Paredes JM; Quiroga S; Ripollés T; Rimola J
    Aliment Pharmacol Ther; 2011 Jul; 34(2):125-45. PubMed ID: 21615440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Tsoulis DJ; MacDonald JK
    Cochrane Database Syst Rev; 2013 Apr; (4):CD000545. PubMed ID: 23633304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sargramostim (GM-CSF) for induction of remission in Crohn's disease.
    Roth L; Macdonald JK; McDonald JW; Chande N
    Cochrane Database Syst Rev; 2011 Nov; (11):CD008538. PubMed ID: 22071853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclosporine for induction of remission in Crohn's disease.
    McDonald JW; Feagan BG; Jewell D; Brynskov J; Stange EF; Macdonald JK
    Cochrane Database Syst Rev; 2005 Apr; (2):CD000297. PubMed ID: 15846602
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis.
    Bellini D; Rivosecchi F; Panvini N; Rengo M; Caruso D; Carbone I; Ferrari R; Paolantonio P; Laghi A
    World J Gastroenterol; 2019 Aug; 25(31):4555-4566. PubMed ID: 31496631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2003; (1):CD003459. PubMed ID: 12535475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate for induction of remission in refractory Crohn's disease.
    Alfadhli AA; McDonald JW; Feagan BG
    Cochrane Database Syst Rev; 2005 Jan; (1):CD003459. PubMed ID: 15674908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.
    Chande N; Townsend CM; Parker CE; MacDonald JK
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD000545. PubMed ID: 27783843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.